Incentives for orphan drug research and development in the United States

BACKGROUND: The Orphan Drug Act (1983) established several incentives to encourage the development of orphan drugs (ODs) to treat rare diseases and conditions. This study analyzed the characteristics of OD designations, approvals, sponsors, and evaluated the effective patent and market exclusivity l...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Seoane-Vazquez, Enrique, Rodriguez-Monguio, Rosa, Szeinbach, Sheryl L, Visaria, Jay
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2008
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2631478/
https://ncbi.nlm.nih.gov/pubmed/19087348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-3-33
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia